Drug Utilization Review Board
Meeting Agenda
Thursday, July 10, 2025
7:15 a.m. to 8:30 a.m.
Google Meet joining info
Video call link: meet.google.com/zue-rrgz-rpb
Or dial: (US) +1 904-900-0180 PIN: 172 873 306#
Persons who wish to address the DUR Board may contact Luis Moreno at lmoreno@utah.gov prior to the meeting, or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints.
1) Call to order - Sharon Weinstein, MD
a) Welcome and Introductions
b) Review and Approval of Minutes
c) Housekeeping - Luis Moreno, PharmD
2) Last DUR Prior Authorization Updates - Luis Moreno, PharmD
a) Tryvio (aprocitentan)
b) Zynteglo (betibeglogene autotemcel)
c) GLP-1 Medications for Weight Loss
3) Review Topic
a) Cobenfy (xanomeline & trospium chloride) DRRC Report - Lauren Heath, PharmD
i) Utilization Review - Luis Moreno, PharmD
ii) Committee Discussion/Questions
4) Public Comment -
a) Bristol Myers Squibb: Cobenfy - Aaron Feyos, MHA
5) Review New Prior Authorization Criteria
a) Spravato (esketamine) - Skylar Fenton, PharmD
i) Committee Discussion/Questions
ii) Committee Action
b) Kebilidi (eladocagene exuparvovec-tneq) - Kyu Yun Park, PharmD
i) Committee Discussion/Questions
ii) Committee Action
c) Adzynma (ADAMTS13, recombinant-krhn) - lris Wan, PharmD
i) Committee Discussion/Questions
ii) Committee Action
d) Cablivi (caplacizumab-yhdp) - Luis Moreno, PharmD
i) Committee Discussion/Questions
ii) Committee Action
6) Next Meeting
a) August 14, 2025 - Journavx (suzetrigine) Report and review new prior authorization criteria: Beqvez, Skysona, and Pigray.
7) Adjourned - Sharon Weinstein, MD
Notice of Special Accommodations (ADA)
In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Luis Moreno at 801-538-6155.
Notice of Electronic or Telephone Participation
Video call link: meet.google.com/zue-rrgz-rpb
Or dial: (US) +1 904-900-0180 PIN: 172 873 306#